학술논문
Clinical Outcomes in Patients With Psoriasis Following Discontinuation of Efalizumab Due to Suspension of Marketing Authorization
Document Type
Article
Author
Source
In Actas dermosifiliográficas (English Edition) 2010 101(5):421-427
Subject
Language
ISSN
1578-2190